Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Oral JAK1/JAK2 Inhibitor INC424 in Adult Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
- Status
- TERMINATED
- Phase
- PHASE1
Ruxolitinib for Chuvash Polycythemia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Ruxolitinib for Adult T-Cell Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
- Status
- COMPLETED
- Phase
- PHASE3
Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Ruxolitinib in Estrogen Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib in Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Study of Ruxolitinib in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2